Tabloid

Drug Details

Thioguanine is a chemotherapy drug used in the treatment of acute myeloid leukemia (AML), a type of acute nonlymphocytic leukemia. It works by interfering with the growth of cancer cells, helping to slow or stop their spread. Thioguanine is taken orally as a tablet once a day. While it is approved by the FDA, it is not widely recommended in current treatment guidelines due to the availability of alternative medications that may be more effective and have fewer severe side effects. Common side effects of thioguanine include a decrease in blood cell counts and potential serious liver issues. Always consult your healthcare provider for advice tailored to your specific health needs before starting any medication.